{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:27:39Z","timestamp":1786980459653,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310071\/2018-6"],"award-info":[{"award-number":["310071\/2018-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005668","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Distrito Federal","doi-asserted-by":"publisher","award":["00193-00000229\/2021-21"],"award-info":[{"award-number":["00193-00000229\/2021-21"]}],"id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00894-022-05252-2","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T01:02:47Z","timestamp":1660093367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["In silico study of tacrine and acetylcholine binding profile with human acetylcholinesterase: docking and electronic structure"],"prefix":"10.1007","volume":"28","author":[{"given":"Let\u00edcia A.","family":"Nascimento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9rica C. M.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8677-3239","authenticated-orcid":false,"given":"Jo\u00e3o B. L.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"issue":"15","key":"5252_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"1510","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M et al (2019) (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 1510(15):565\u2013581. https:\/\/doi.org\/10.1038\/s41582-019-0244-7","journal-title":"Nat Rev Neurol"},{"key":"5252_CR2","doi-asserted-by":"publisher","unstructured":"Weis S, Sonnberger M, Dunzinger A, et al (2019) Neurodegenerative diseases: Alzheimer disease (AD). Imaging Brain Dis 897\u2013931. https:\/\/doi.org\/10.1007\/978-3-7091-1544-2_32","DOI":"10.1007\/978-3-7091-1544-2_32"},{"key":"5252_CR3","doi-asserted-by":"publisher","first-page":"186813","DOI":"10.1155\/2010\/186813","volume":"2010","author":"H-L Zhang","year":"2010","unstructured":"Zhang H-L, Wu J, Zhu J (2010) The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Dev Immunol 2010:186813. https:\/\/doi.org\/10.1155\/2010\/186813","journal-title":"Clin Dev Immunol"},{"issue":"9","key":"5252_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"92","author":"C-C Liu","year":"2013","unstructured":"Liu C-C, Kanekiyo T, Xu H (2013) Bu G (2013) Apolipoprotein E and Alzheimer disease: risk mechanisms and therapy. Nat Rev Neurol 92(9):106\u2013118. https:\/\/doi.org\/10.1038\/nrneurol.2012.263","journal-title":"Nat Rev Neurol"},{"key":"5252_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0891988710383571","volume":"23","author":"B Lm","year":"2010","unstructured":"Lm B, Ce Y, Td B, DW T, (2010) Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol 23:213\u2013227. https:\/\/doi.org\/10.1177\/0891988710383571","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"5252_CR6","doi-asserted-by":"publisher","unstructured":"Martorana A, Esposito Z, Koch G (2010) Beyond the cholinergic hypothesis: do current drugs work in Alzheimer\u2019s disease? CNS Neurosci Ther 16:no--no https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00175.x","DOI":"10.1111\/j.1755-5949.2010.00175.x"},{"key":"5252_CR7","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1001\/jama.287.18.2335","volume":"287","author":"JL Cummings","year":"2002","unstructured":"Cummings JL, Cole G (2002) Alzheimer disease. J Am Med Assoc 287:2335\u20132338","journal-title":"J Am Med Assoc"},{"key":"5252_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cplett.2008.05.006","volume":"458","author":"ECM Nascimento","year":"2008","unstructured":"Nascimento ECM, Martins JBL, dos Santos ML, Gargano R (2008) Theoretical study of classical acetylcholinesterase inhibitors. Chem Phys Lett 458:285\u2013289. https:\/\/doi.org\/10.1016\/j.cplett.2008.05.006","journal-title":"Chem Phys Lett"},{"key":"5252_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/j.1460-9568.2003.02732.x","volume":"18","author":"T Ohno-Shosaku","year":"2003","unstructured":"Ohno-Shosaku T, Matsui M, Fukudome Y et al (2003) Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur J Neurosci 18:109\u2013116. https:\/\/doi.org\/10.1046\/j.1460-9568.2003.02732.x","journal-title":"Eur J Neurosci"},{"key":"5252_CR10","doi-asserted-by":"publisher","unstructured":"Yi JH, Whitcomb DJ, Park SJ, et al (2020) M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer\u2019s disease pathology. Brain Commun 2 https:\/\/doi.org\/10.1093\/braincomms\/fcaa058","DOI":"10.1093\/braincomms\/fcaa058"},{"key":"5252_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/ejn.15074","volume":"53","author":"E Suzuki","year":"2021","unstructured":"Suzuki E, Momiyama T (2021) M1 muscarinic acetylcholine receptor-mediated inhibition of GABA release from striatal medium spiny neurons onto cholinergic interneurons. Eur J Neurosci 53:796\u2013813. https:\/\/doi.org\/10.1111\/ejn.15074","journal-title":"Eur J Neurosci"},{"key":"5252_CR12","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.neuron.2018.06.018","volume":"98","author":"MG Baxter","year":"2018","unstructured":"Baxter MG, Crimins JL (2018) Acetylcholine receptor stimulation for cognitive enhancement: better the devil you know? Neuron 98:1064\u20131066. https:\/\/doi.org\/10.1016\/j.neuron.2018.06.018","journal-title":"Neuron"},{"key":"5252_CR13","doi-asserted-by":"publisher","unstructured":"Anand P, Singh B (2013) A review on cholinesterase inhibitors for Alzheimer\u2019s disease. Arch Pharm Res 36:375\u2013339. https:\/\/doi.org\/10.1007\/s12272-013-0036-3","DOI":"10.1007\/s12272-013-0036-3"},{"key":"5252_CR14","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1021\/jm800577j","volume":"51","author":"M Rosini","year":"2008","unstructured":"Rosini M, Simoni E, Bartolini M et al (2008) Inhibition of acetylcholinesterase, \u03b2-amyloid aggregation, and NMDA receptors in Alzheimer\u2019s disease: a promising direction for the multi-target-directed ligands gold rush. J Med Chem 51:4381\u20134384. https:\/\/doi.org\/10.1021\/jm800577j","journal-title":"J Med Chem"},{"key":"5252_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2174\/1570159x14666160119094820","volume":"14","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang H, Chen H (2016) AChE inhibition-based multi-target-directed ligands, a novel pharmacological approach for the symptomatic and disease-modifying therapy of Alzheimer\u2019s disease. Curr Neuropharmacol 14:364\u2013375. https:\/\/doi.org\/10.2174\/1570159x14666160119094820","journal-title":"Curr Neuropharmacol"},{"key":"5252_CR16","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1021\/acs.accounts.1c00457","volume":"54","author":"J Han","year":"2021","unstructured":"Han J, Du Z, Lim MH (2021) Mechanistic insight into the design of chemical tools to control multiple pathogenic features in Alzheimer\u2019s disease. Acc Chem Res 54:3930\u20133940. https:\/\/doi.org\/10.1021\/acs.accounts.1c00457","journal-title":"Acc Chem Res"},{"key":"5252_CR17","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1080\/07391102.2020.1844054","volume":"40","author":"N Kumar","year":"2022","unstructured":"Kumar N, Gahlawat A, Kumar RN et al (2022) Drug repurposing for Alzheimer\u2019s disease: in silico and in vitro investigation of FDA-approved drugs as acetylcholinesterase inhibitors. J Biomol Struct Dyn 40:2878\u20132892. https:\/\/doi.org\/10.1080\/07391102.2020.1844054","journal-title":"J Biomol Struct Dyn"},{"key":"5252_CR18","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3389\/fphar.2018.01192","volume":"9","author":"TC dos Santos","year":"2018","unstructured":"dos Santos TC, Gomes TM, Pinto BAS et al (2018) Naturally occurring acetylcholinesterase inhibitors and their potential use for Alzheimer\u2019s disease therapy. Front Pharmacol 9:1192. https:\/\/doi.org\/10.3389\/fphar.2018.01192","journal-title":"Front Pharmacol"},{"key":"5252_CR19","doi-asserted-by":"publisher","unstructured":"Abdul Manap AS, Wei Tan AC, Leong WH et al (2019) Synergistic effects of curcumin and piperine as potent acetylcholine and amyloidogenic inhibitors with significant neuroprotective activity in SH-SY5Y cells via computational molecular modeling and in vitro assay. Front Aging Neurosci 11 https:\/\/doi.org\/10.3389\/fnagi.2019.00206","DOI":"10.3389\/fnagi.2019.00206"},{"key":"5252_CR20","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.ijbiomac.2021.10.204","volume":"193","author":"JB Shaik","year":"2021","unstructured":"Shaik JB, Kandrakonda YR, Kallubai M et al (2021) Deciphering the AChE-binding mechanism with multifunctional tricyclic coumarin anti-Alzheimer\u2019s agents using biophysical and bioinformatics approaches and evaluation of their modulating effect on Amyloidogenic peptide assembly. Int J Biol Macromol 193:1409\u20131420. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.10.204","journal-title":"Int J Biol Macromol"},{"key":"5252_CR21","doi-asserted-by":"publisher","first-page":"116357","DOI":"10.1016\/j.bmc.2021.116357","volume":"46","author":"R YudiUtomo","year":"2021","unstructured":"YudiUtomo R, Asawa Y, Okada S et al (2021) Development of curcumin-based amyloid \u03b2 aggregation inhibitors for Alzheimer\u2019s disease using the SAR matrix approach. Bioorg Med Chem 46:116357. https:\/\/doi.org\/10.1016\/j.bmc.2021.116357","journal-title":"Bioorg Med Chem"},{"key":"5252_CR22","doi-asserted-by":"crossref","unstructured":"Liao Y, Hu X, Pan J, Zhang G (2022) Inhibitory mechanism of baicalein on acetylcholinesterase: inhibitory interaction, conformational change, and computational simulation. Foods 11","DOI":"10.3390\/foods11020168"},{"key":"5252_CR23","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.2174\/15680266113139990139","volume":"13","author":"E Viayna","year":"2013","unstructured":"Viayna E, Sabate R, Mu\u00f1oz-Torrero D (2013) Dual inhibitors of \u03b2-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates. Curr Top Med Chem 13:1820\u20131842. https:\/\/doi.org\/10.2174\/15680266113139990139","journal-title":"Curr Top Med Chem"},{"key":"5252_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5530\/pres.14.1.8","volume":"14","author":"BY Koide da Silva","year":"2021","unstructured":"Koide da Silva BY, da Neves Lopes A, S, Jos\u00e9 Sousa Maia P, et al (2021) Chemical and biological evaluation of the aqueous extract of Peumus boldus Molina (Monimiaceae) leaves. Pharmacognosy Res 14:45\u201352. https:\/\/doi.org\/10.5530\/pres.14.1.8","journal-title":"Pharmacognosy Res"},{"key":"5252_CR25","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1021\/acschemneuro.1c00521","volume":"12","author":"T Meira Menezes","year":"2021","unstructured":"Meira Menezes T, Assis C, Lacerda Cintra AJ et al (2021) Binding mechanism between acetylcholinesterase and drugs pazopanib and lapatinib: biochemical and biophysical studies. ACS Chem Neurosci 12:4500\u20134511. https:\/\/doi.org\/10.1021\/acschemneuro.1c00521","journal-title":"ACS Chem Neurosci"},{"key":"5252_CR26","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1039\/D1MD00046B","volume":"12","author":"RG de Andrade","year":"2021","unstructured":"de Andrade RG, Souza de Oliveira A, Bartolini M et al (2021) Discovery of sustainable drugs for Alzheimer\u2019s disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties. RSC Med Chem 12:1154\u20131163. https:\/\/doi.org\/10.1039\/D1MD00046B","journal-title":"RSC Med Chem"},{"key":"5252_CR27","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0959-440X(92)90207-N","volume":"2","author":"JL Sussman","year":"1992","unstructured":"Sussman JL, Silman I (1992) Acetylcholinesterase: structure and use as a model for specific cation\u2014protein interactions. Curr Opin Struct Biol 2:721\u2013729. https:\/\/doi.org\/10.1016\/0959-440X(92)90207-N","journal-title":"Curr Opin Struct Biol"},{"key":"5252_CR28","doi-asserted-by":"publisher","first-page":"12074","DOI":"10.1021\/bi00096a018","volume":"32","author":"Z Radic","year":"1993","unstructured":"Radic Z, Pickering NA, Vellom DC et al (1993) Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. Biochemistry 32:12074\u201312084. https:\/\/doi.org\/10.1021\/bi00096a018","journal-title":"Biochemistry"},{"key":"5252_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0009-2797(99)00014-9","volume":"119\u2013120","author":"A Saxena","year":"1999","unstructured":"Saxena A, Redman AMG, Jiang X et al (1999) Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Chem Biol Interact 119\u2013120:61\u201369. https:\/\/doi.org\/10.1016\/S0009-2797(99)00014-9","journal-title":"Chem Biol Interact"},{"key":"5252_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0301-0082(91)90002-I","volume":"36","author":"SE Freeman","year":"1991","unstructured":"Freeman SE, Dawson RM (1991) Tacrine: a pharmacological review. Prog Neurobiol 36:257\u2013277. https:\/\/doi.org\/10.1016\/0301-0082(91)90002-I","journal-title":"Prog Neurobiol"},{"key":"5252_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0009-2797(93)90042-W","volume":"87","author":"JL Sussman","year":"1993","unstructured":"Sussman JL, Harel M, Silman I (1993) Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs. Chem Biol Interact 87:187\u2013197. https:\/\/doi.org\/10.1016\/0009-2797(93)90042-W","journal-title":"Chem Biol Interact"},{"issue":"9031","key":"5252_CR32","doi-asserted-by":"publisher","first-page":"LP \u2013 9035","DOI":"10.1073\/pnas.90.19.9031","volume":"90","author":"M Harel","year":"1993","unstructured":"Harel M, Schalk I, Ehret-Sabatier L et al (1993) Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci 90(9031):LP-9035. https:\/\/doi.org\/10.1073\/pnas.90.19.9031","journal-title":"Proc Natl Acad Sci"},{"key":"5252_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0304-3940(90)90254-7","volume":"118","author":"RM Dawson","year":"1990","unstructured":"Dawson RM (1990) Reversibility of the inhibition of acetylcholinesterase by tacrine. Neurosci Lett 118:85\u201387. https:\/\/doi.org\/10.1016\/0304-3940(90)90254-7","journal-title":"Neurosci Lett"},{"issue":"(suppl 3","key":"5252_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000116478","volume":"29","author":"WK Summers","year":"1989","unstructured":"Summers WK, Tachiki KH, Kling A (1989) Tacrine in the treatment of Alzheimer\u2019s disease. Eur Neurol 29((suppl 3):28\u201332. https:\/\/doi.org\/10.1159\/000116478","journal-title":"Eur Neurol"},{"key":"5252_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1600-0404.1992.tb04458.x","volume":"85","author":"A Adem","year":"1992","unstructured":"Adem A (1992) Putative mechanisms of action of tacrine in Alzheimer\u2019s disease. Acta Neurol Scand 85:69\u201374. https:\/\/doi.org\/10.1111\/j.1600-0404.1992.tb04458.x","journal-title":"Acta Neurol Scand"},{"key":"5252_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-017-3548-9","volume":"24","author":"NM Borges","year":"2018","unstructured":"Borges NM, Sartori GR, Ribeiro JFR et al (2018) Similarity search combined with docking and molecular dynamics for novel hAChE inhibitor scaffolds. J Mol Model 24:1\u201312. https:\/\/doi.org\/10.1007\/s00894-017-3548-9","journal-title":"J Mol Model"},{"key":"5252_CR37","first-page":"S160","volume":"42","author":"AS Kiametis","year":"2013","unstructured":"Kiametis AS, Gargano R, Martins JBL (2013) Anacardic acid as potential acetylcholinesterase inhibitor. Eur Biophys J with Biophys Lett 42:S160\u2013S160","journal-title":"Eur Biophys J with Biophys Lett"},{"key":"5252_CR38","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1016\/j.ejmech.2009.03.045","volume":"44","author":"AAN de Paula","year":"2009","unstructured":"de Paula AAN, Martins JBL, dos Santos ML et al (2009) New potential AChE inhibitor candidates. Eur J Med Chem 44:3754\u20133759. https:\/\/doi.org\/10.1016\/j.ejmech.2009.03.045","journal-title":"Eur J Med Chem"},{"key":"5252_CR39","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1021\/acs.jcim.7b00037","volume":"57","author":"\u00c9CM Nascimento","year":"2017","unstructured":"Nascimento \u00c9CM, Oliva M, \u015awiderek K et al (2017) Binding analysis of some classical acetylcholinesterase inhibitors: insights for a rational design using free energy perturbation method calculations with QM\/MM MD simulations. J Chem Inf Model 57:958\u2013976. https:\/\/doi.org\/10.1021\/acs.jcim.7b00037","journal-title":"J Chem Inf Model"},{"key":"5252_CR40","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00894-010-0838-x","volume":"17","author":"ECM Nascimento","year":"2011","unstructured":"Nascimento ECM, Martins JBLJBL, Moreno Nascimento EC et al (2011) Electronic structure and PCA analysis of covalent and non-covalent acetylcholinesterase inhibitors. J Mol Model 17:1371\u20131379. https:\/\/doi.org\/10.1007\/s00894-010-0838-x","journal-title":"J Mol Model"},{"key":"5252_CR41","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.biopha.2018.03.007","volume":"101","author":"H Khan","year":"2018","unstructured":"Khan H, Marya Amin S et al (2018) Flavonoids as acetylcholinesterase inhibitors: current therapeutic standing and future prospects. Biomed Pharmacother 101:860\u2013870. https:\/\/doi.org\/10.1016\/j.biopha.2018.03.007","journal-title":"Biomed Pharmacother"},{"key":"5252_CR42","doi-asserted-by":"publisher","first-page":"1800050","DOI":"10.1002\/ardp.201800050","volume":"351","author":"N Chufarova","year":"2018","unstructured":"Chufarova N, Czarnecka K, Skibi\u0144ski R et al (2018) New tacrine\u2013acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer\u2019s disease. Arch Pharm (Weinheim) 351:1800050. https:\/\/doi.org\/10.1002\/ardp.201800050","journal-title":"Arch Pharm (Weinheim)"},{"key":"5252_CR43","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20130013","volume":"453","author":"F Nachon","year":"2013","unstructured":"Nachon F, Carletti E, Ronco C et al (2013) Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer\u2019s drugs targeting acetyl- and butyryl-cholinesterase. Biochem J 453:393\u2013399. https:\/\/doi.org\/10.1042\/BJ20130013","journal-title":"Biochem J"},{"key":"5252_CR44","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1021\/ACS.MOLPHARMACEUT.8B01058","volume":"16","author":"VK Meena","year":"2019","unstructured":"Meena VK, Chaturvedi S, Sharma RK et al (2019) Potent acetylcholinesterase selective and reversible homodimeric agent based on tacrine for theranostics. Mol Pharm 16:2296\u20132308. https:\/\/doi.org\/10.1021\/ACS.MOLPHARMACEUT.8B01058","journal-title":"Mol Pharm"},{"key":"5252_CR45","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00894-015-2797-8","volume":"21","author":"A Zhou","year":"2015","unstructured":"Zhou A, Hu J, Wang L et al (2015) Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer\u2019s disease. J Mol Model 21:277. https:\/\/doi.org\/10.1007\/s00894-015-2797-8","journal-title":"J Mol Model"},{"key":"5252_CR46","doi-asserted-by":"publisher","first-page":"e2322","DOI":"10.7717\/PEERJ.2322","volume":"4","author":"S Simeon","year":"2016","unstructured":"Simeon S, Anuwongcharoen N, Shoombuatong W et al (2016) Probing the origins of human acetylcholinesterase inhibition via QSAR modeling and molecular docking. PeerJ 4:e2322. https:\/\/doi.org\/10.7717\/PEERJ.2322","journal-title":"PeerJ"},{"key":"5252_CR47","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1007\/s00894-014-2298-1","volume":"20","author":"WF Cunha","year":"2014","unstructured":"Cunha WF, Gargano R, Garcia E et al (2014) Rovibrational energy and spectroscopic constant calculations of CH 4 \u22ef CH4, CH 4 \u22ef H2 O, CH 4 \u22ef CHF3, and H 2O \u22ef CHF3 dimers. J Mol Model 20:2298. https:\/\/doi.org\/10.1007\/s00894-014-2298-1","journal-title":"J Mol Model"},{"key":"5252_CR48","doi-asserted-by":"publisher","unstructured":"Pereira WA, Nascimento \u00c9CM, Martins JBL (2021) Electronic and structural study of T315I mutated form in DFG-out conformation of BCR-ABL inhibitors https:\/\/doi.org\/10.1080\/07391102.2021.1935320","DOI":"10.1080\/07391102.2021.1935320"},{"key":"5252_CR49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00894-019-4065-9","volume":"25","author":"EL Graef","year":"2019","unstructured":"Graef EL, Martins JBL (2019) Analysis of lowest energy transitions at TD-DFT of pyrene in vacuum and solvent. J Mol Model 25:183. https:\/\/doi.org\/10.1007\/s00894-019-4065-9","journal-title":"J Mol Model"},{"key":"5252_CR50","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00894-021-04925-8","volume":"27","author":"KML Rocha","year":"2021","unstructured":"Rocha KML, Nascimento \u00c9CM, Martins JBL (2021) Investigation on the interaction behavior of afatinib, dasatinib, and imatinib docked to the BCR-ABL protein. J Mol Model 27:309. https:\/\/doi.org\/10.1007\/s00894-021-04925-8","journal-title":"J Mol Model"},{"key":"5252_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.5935\/1984-6835.20160035","volume":"8","author":"AL de Almeida","year":"2016","unstructured":"de Almeida AL, Barbosa LPG, Santos RL, Martins JBL (2016) Chemical reactivity indices of the caffeine molecule. Rev Virtual Qu\u00edmica 8:483\u2013492. https:\/\/doi.org\/10.5935\/1984-6835.20160035","journal-title":"Rev Virtual Qu\u00edmica"},{"key":"5252_CR52","unstructured":"Frisch MJ, Trucksr GW, Schlegel HB et al (2009) Gaussian09 Revision D01. Gaussian Inc., Wallingford CT"},{"key":"5252_CR53","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MHM Olsson","year":"2011","unstructured":"Olsson MHM, S\u00f8ndergaard CR, Rostkowski M, Jensen JH (2011) PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions. J Chem Theory Comput 7:525\u2013537. https:\/\/doi.org\/10.1021\/ct100578z","journal-title":"J Chem Theory Comput"},{"key":"5252_CR54","doi-asserted-by":"publisher","unstructured":"Morris GM, Huey R, Lindstrom W et al  (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/JCC.21256","DOI":"10.1002\/JCC.21256"},{"key":"5252_CR55","doi-asserted-by":"publisher","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: Visual molecular dynamics J Mol Graph https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","DOI":"10.1016\/0263-7855(96)00018-5"},{"key":"5252_CR56","unstructured":"Dassault Syst\u00e8mes BIOVIA (2017) Discovery Studio, 2017. Dassault Syst\u00e8mes,\u00a0San Diego, CA"},{"key":"5252_CR57","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.1021\/ja100936w","volume":"132","author":"ER Johnson","year":"2010","unstructured":"Johnson ER, Keinan S, Mori-S\u00e1nchez P et al (2010) Revealing noncovalent interactions. J Am Chem Soc 132:6498\u20136506. https:\/\/doi.org\/10.1021\/ja100936w","journal-title":"J Am Chem Soc"},{"key":"5252_CR58","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00214-016-1977-7","volume":"135","author":"J Contreras-Garc\u00eda","year":"2016","unstructured":"Contreras-Garc\u00eda J, Boto RA, Izquierdo-Ruiz F et al (2016) A benchmark for the non-covalent interaction (NCI) index or\u2026is it really all in the geometry? Theor Chem Acc 135:242. https:\/\/doi.org\/10.1007\/s00214-016-1977-7","journal-title":"Theor Chem Acc"},{"key":"5252_CR59","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1021\/ct100641a","volume":"7","author":"J Contreras-Garc\u00eda","year":"2011","unstructured":"Contreras-Garc\u00eda J, Johnson ER, Keinan S et al (2011) NCIPLOT: a program for plotting noncovalent interaction regions. J Chem Theory Comput 7:625\u2013632. https:\/\/doi.org\/10.1021\/ct100641a","journal-title":"J Chem Theory Comput"},{"key":"5252_CR60","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/jcc.22885","volume":"33","author":"T Lu","year":"2012","unstructured":"Lu T, Chen F (2012) Multiwfn: a multifunctional wavefunction analyzer. J Comput Chem 33:580\u2013592. https:\/\/doi.org\/10.1002\/jcc.22885","journal-title":"J Comput Chem"},{"key":"5252_CR61","doi-asserted-by":"publisher","first-page":"10078","DOI":"10.1021\/jp2056859","volume":"115","author":"F Fuster","year":"2011","unstructured":"Fuster F, Grabowski SJ (2011) Intramolecular hydrogen bonds: the QTAIM and ELF characteristics. J Phys Chem A 115:10078\u201310086. https:\/\/doi.org\/10.1021\/jp2056859","journal-title":"J Phys Chem A"},{"key":"5252_CR62","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1016\/S0006-3495(02)75609-9","volume":"82","author":"RH Henchman","year":"2002","unstructured":"Henchman RH, Tai K, Shen T, McCammon JA (2002) Properties of water molecules in the active site gorge of acetylcholinesterase from computer simulation. Biophys J 82:2671\u20132682. https:\/\/doi.org\/10.1016\/S0006-3495(02)75609-9","journal-title":"Biophys J"},{"key":"5252_CR63","doi-asserted-by":"publisher","first-page":"7073","DOI":"10.1021\/jm5008648","volume":"57","author":"S Hamulakova","year":"2014","unstructured":"Hamulakova S, Janovec L, Hrabinova M et al (2014) Synthesis and biological evaluation of novel tacrine derivatives and tacrine\u2013coumarin hybrids as cholinesterase inhibitors. J Med Chem 57:7073\u20137084. https:\/\/doi.org\/10.1021\/jm5008648","journal-title":"J Med Chem"},{"key":"5252_CR64","doi-asserted-by":"publisher","first-page":"108698","DOI":"10.1016\/j.cbi.2019.06.011","volume":"309","author":"O Gerlits","year":"2019","unstructured":"Gerlits O, Ho KY, Cheng X et al (2019) A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies. Chem Biol Interact 309:108698. https:\/\/doi.org\/10.1016\/j.cbi.2019.06.011","journal-title":"Chem Biol Interact"},{"key":"5252_CR65","doi-asserted-by":"publisher","first-page":"10282","DOI":"10.1021\/jm300871x","volume":"55","author":"J Cheung","year":"2012","unstructured":"Cheung J, Rudolph MJ, Burshteyn F et al (2012) Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem 55:10282\u201310286. https:\/\/doi.org\/10.1021\/jm300871x","journal-title":"J Med Chem"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-022-05252-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-022-05252-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-022-05252-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T21:04:05Z","timestamp":1662757445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-022-05252-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["5252"],"URL":"https:\/\/doi.org\/10.1007\/s00894-022-05252-2","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"assertion":[{"value":"14 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"252"}}